The global therapeutic
drug monitoring market is foreseen to grow by 8.8%, from USD 15.75 Billion in
2021 to USD 3.42 Billion in 2029. Growing focus on R&D related to tdm, importance
of tdm in organ transplant procedures, increasing preference for precision
medicine is to drive the market for the upcoming forecast period. However, reluctance
of small hospitals to offer tdm services, requirement of high capital
investments remains one factor hindering the market growth over the anticipated
period.
Market Definition
What is Therapeutic drug
monitoring?
Therapeutic drug monitoring (TDM) is testing that
measures the amount of certain medicines in your blood. It is done to make sure
the amount of medicine you are taking is both safe and effective.
Market Overview
The
therapeutic drug monitoring market search study helps to thoroughly
understand the current trend in the market competitive analysis of the players
in the emerging market. Moreover, the DRO in the therapeutic drug monitoring
market offers valuable perspicuity and a current scenario for making the right
decision. The research study covers the eminent players in the market with a
detailed analysis of the company and a financial overview containing their net
sales, business mix and geographical reach It mainly focuses on the key
developments of the products/services offered by the company in recent years.
Besides, we at Zettabyte have the expertise to analyses the global therapeutic
drug monitoring market player's competitive landscape helping the client
comprehend their specific strategic growth approaches.
Therapeutic
drug monitoring market study by "Zettabyte Analytics" offers details
about the market scope, market segmentation, technological advancement in the therapeutic
drug monitoring market and highlights the optimistic, competitive landscape and
trends enduring over the years.
Major players in
the therapeutic drug monitoring market include Aalto Scientific, Ltd., Abbott,
Apdia Group, Ark Diagnostics, Inc., Biomérieux Sa, Bio-Rad Laboratories, Biotez
Berlin Buch Gmbh, Bühlmann Laboratories, Cambridge Life Sciences Limited,
Danaher Corporation, Diasystem Scandinavia Ab, Eagle Biosciences, Inc., Exagen
Inc., F. Hoffmann-La Roche, Grifols S.A., Hromsystems Instruments &
Chemicals Gmbh, Immundiagnostik Ag., Jasem Laboratory Systems And Solutions,
Randox Laboratories Ltd., R-Biopharm Ag, Sekisui Medical Co., Ltd., Siemens
Healthineers Ag, Theradiag Sa., Thermo Fisher Scientific, Utak.
COVID-19 Impact on Global Therapeutic
drug monitoring Market
The global impact
of COVID-19 has lost millions of lives with a massive cost to the healthcare
system. Moreover, the treatment cost for patients with COVID-19 has also had a
financial impact globally. the impact of COVID-19 on the therapeutic drug
monitoring market has forced the companies to change their sourcing, pricing,
and promotion strategies. the therapeutic drug monitoring market players are
seen focusing more on optimizing the e-commerce networks with the rising
innovations in the digital sector, which are creating new business models for
the healthcare industry player.
Research Scope
The report
provides market value for the base year 2021 and a yearly forecast from 2022 to
2029 in revenue (USD Million/ Billion). the market for each segment is present
in North America, Europe, Asia Pacific, Latin America, Middle East &
Africa, and the regional basis for the forecast mentioned above.
Key industry
dynamics, regulatory scenarios, major material dynamics and therapeutic drug
monitoring market future markets are analyzed to understand their impact on demand
for the forecast period. growth rates have been estimated using correlation,
regression and time-series analysis.
Market Segmentation
For the purpose
of this report, the global therapeutic drug monitoring market segmented on the
basis of product type, technology, class of drug, end user, and region:
Product Type Outlook:
On the basis of
Product Type, the market is segmented into Equipment, Consumables. Further,
Equipment is segmented into Immunoassay Analyzers, Chromatography and MS
Detectors, Clinical Chemistry Analyzers.
Technology Outlook:
On the basis of
Technology, the market is segmented into Immunoassays, Chromatography-Mass
spectrometry. Further, Immunoassays is segmented into Radioimmunoassays,
Colorimetric Immunoassays, Other Immunoassays. Further, Chromatography-Mass
spectrometry is segmented into Liquid chromatography/mass spectrometry (LC-MS),
Gas Chromatography-Mass Spectrometry.
Figure 1 Therapeutic drug monitoring Market
By Technology (Market Size And Forecast By Value - USD Million, 2021 &
2029)

Class of Drug Outlook:
On the basis of
Class of Drug, the market is segmented into Antiepileptic Drugs, Antiarrhythmic
Drugs, Immunosuppressant Drugs, Antibiotic Drugs, Bronchodilator Drugs,
Psychoactive Drugs, Other drug classes.
End Use Outlook:
On the basis of
End User, the market is segmented into Commercial/Private Labs, Hospital Labs,
Other End Users.
Figure 2 End Use Outlook (Revenue, USD Million, 2021)

Regional Outlook (Revenue, USD million; 2021
& 2029)
Regional Outlook
(Revenue, USD million; 2018-2029)
|
North America
|
U.S.
|
|
Canada
|
Europe
|
Germany
|
|
U.K.
|
|
France
|
|
Spain
|
|
Italy
|
|
Rest of the Europe
|
Asia Pacific
|
India
|
|
Japan
|
|
China
|
|
South Korea
|
|
Australia
|
|
Rest of Asia-Pacific
|
Middle East & Africa
|
UAE
|
|
Saudi Arabia
|
|
South Africa
|
|
Rest of Middle East & Africa
|
Latin America
|
Brazil
|
|
Mexico
|
|
Argentina
|
|
Rest of Latin America
|
Figure 3 Therapeutic Drug Monitoring Market:
Regional Dynamics
